Weight loss with medication involves the use of pharmaceutical interventions to aid in achieving weight loss goals. Medications prescribed by healthcare professionals may help suppress appetite, reduce fat absorption, or increase metabolism. They are typically used in conjunction with lifestyle modifications and under medical supervision.
-
Ozempic/Semaglutide
Used SQ once a week to reach desired goal. This is a FDA approved GLP1 medication that can be used off-label to target stubborn belly fat. *Pricing varies with dosage
-
Mounjaro/Tirzepatide
Used SQ once a week to reach desired goals. This is a FDA approved GLP1 medication that can be used off lable to target stubborn belly Fat. *COMING SOON
-
Oral Medications
Oral appetite suppressants such as phentermine may also be used alone or in conjunction with other weight loss management.
SEMAGLUTIDE INJECTION/ MOUNJARO INJECTION
- One of the most successful medications approved by the FDA for weight loss
- Easy once weekly subcutaneous injection
- Used for weight loss in obese adults (BMI>29)
- Used in overweight individuals with weight related medical problems to help them lose and keep the weight off
- Much more effective in the amount of weight loss it produces compared to other currently available FDA approved drugs on the market.
- Additional benefits of controlling blood sugar and reducing cardiovascular event risk
- Best results with reduced calorie meal plan and increased physical activity
- Not a controlled substance
RECOMMENDED DOSAGE
Semaglutide therapy should be initiated with a dose of 0.25mg once weekly on the same day, then follow dose escalation schedule.
DOSE ESCALATION SCHEDULE
|
WEEKS |
WEEKLY DOSE |
INJECT |
|
|
1-4 |
0.25MG |
0.75ml = 75 units |
INITIATION DOSE |
|
5-8 |
0.5MG |
0.75ml = 75 units |
DOSE ESCALATION |
|
9-12 |
1MG |
0.75ml = 75 units |
DOSE ESCALATION |
|
13-16 |
1.7MG |
0.75ml = 75 units |
DOSE ESCALATION |
|
17 AND ONWARD |
2.4MG |
0.75ml = 75 units |
MAINTENANCE DOSE |
HOW TO USE SEMAGLUTIDE INJECTION
Inject subcutaneously in the abdomen, thigh, or upper arm.
DO NOT USE SEMAGLUTIDE IF:
- Pregnant
- Family history of medullary thyroid carcinoma
- Personal history of pancreatitis
- Prior serious hypersensitivity to semaglutide
PRECAUTIONS
- Females and Males of reproductive potential should discontinue semaglutide 2 months prior to planned pregnancy.
- Follow escalation schedule and stay hydrated in order to reduce possibilities of side effects such as constipation, nausea or vomiting, excessively low blood sugar.
- Consider reducing the dose of insulin in patients on insulin therapy as semaglutide also stimulates insulin secretion to control high blood sugar levels.
STORAGE
- Semaglutide should be protected from light
- Store in the refrigerator. However once punctured, vial is good at room temperature for 28 days.
- Do not freeze
- Do not use if stored at room temperature for longer than 28 day